Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$509M |
| 2 |
Mastercard
MA
|
+$404M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$401M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$302M |
| 5 |
Intuit
INTU
|
+$277M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$416M |
| 2 |
Coca-Cola
KO
|
+$394M |
| 3 |
Starbucks
SBUX
|
+$374M |
| 4 |
Salesforce
CRM
|
+$351M |
| 5 |
PNC Financial Services
PNC
|
+$268M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.34% |
| 2 | Financials | 9.88% |
| 3 | Consumer Discretionary | 8.94% |
| 4 | Industrials | 7.09% |
| 5 | Healthcare | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
WisdomTree
WT
$3.61B
| $700K | ﹤0.01% |
78,472
-339,952
| -81% | -$3.17M |
|
2127
HCA Healthcare
HCA
$92.9B
| $699K | ﹤0.01% |
2,024
-7,382
| -78% | -$2.37M |
|
2128
GoDaddy
GDDY
$12.7B
| $699K | ﹤0.01% |
+3,882
| New | +$742K |
|
2129
Iovance Biotherapeutics
IOVA
$3.65B
| $699K | ﹤0.01% |
209,941
-2,609,858
| -93% | -$13.5M |
|
2130
Intercorp Financial Services
IFS
$6.07B
| $699K | ﹤0.01% |
21,088
+10,685
| +103% | +$336K |
|
2131
New Mountain Finance
NMFC
$722M
| $697K | ﹤0.01% |
+63,208
| New | +$721K |
|
2132
American Express Global Business Travel
GBTG
$4.95B
| $697K | ﹤0.01% |
+95,942
| New | +$809K |
|
2133
Weibo
WB
$1.72B
| $695K | ﹤0.01% |
73,367
+44,462
| +154% | +$452K |
|
2134
CALL
Robinhood
HOOD
$93.2B
| $691K | ﹤0.01% |
16,600
-212,100
| -93% | -$10.1M |
|
|
REE
2135
DELISTED
REE Automotive
REE
| $690K | ﹤0.01% |
259,578
-192,866
| -43% | -$1.38M |
|
2136
LKQ Corp
LKQ
$6.51B
| $689K | ﹤0.01% |
16,198
-131,988
| -89% | -$5.23M |
|
|
IMSR
2137
Terrestrial Energy
IMSR
$550M
| $687K | ﹤0.01% |
+65,000
| New | +$659K |
|
|
ATYR
2138
aTyr Pharma
ATYR
$52M
| $686K | ﹤0.01% |
227,142
+182,832
| +413% | +$667K |
|
2139
Grupo Cibest SA
CIB
$24B
| $686K | ﹤0.01% |
17,053
-5,663
| -25% | -$222K |
|
2140
MaxLinear
MXL
$5.69B
| $684K | ﹤0.01% |
62,992
-58,194
| -48% | -$973K |
|
2141
Westamerica Bancorp
WABC
$1.35B
| $684K | ﹤0.01% |
13,511
+6,218
| +85% | +$317K |
|
|
AXON
2142
PUT
Axon Enterprise
AXON
$48.5B
| $684K | ﹤0.01% |
+1,300
| New | +$761K |
|
2143
Manulife Financial
MFC
$71B
| $681K | ﹤0.01% |
21,833
+11,844
| +119% | +$358K |
|
|
EXOD
2144
Exodus Movement Inc
EXOD
$237M
| $675K | ﹤0.01% |
+14,766
| New | +$654K |
|
2145
OneMain Financial
OMF
$7.23B
| $674K | ﹤0.01% |
+13,782
| New | +$731K |
|
2146
Uber
UBER
$162B
| $672K | ﹤0.01% |
9,228
-175,323
| -95% | -$12.6M |
|
2147
Health Catalyst
HCAT
$120M
| $671K | ﹤0.01% |
+148,140
| New | +$784K |
|
2148
Tyler Technologies
TYL
$14.6B
| $671K | ﹤0.01% |
1,154
-16,394
| -93% | -$9.74M |
|
2149
CALL
BridgeBio Pharma
BBIO
$15.8B
| $671K | ﹤0.01% |
+19,400
| New | +$654K |
|
2150
Targa Resources
TRGP
$63.1B
| $666K | ﹤0.01% |
3,323
-792,397
| -100% | -$157M |
|
Similar funds
Dmitry Balyasny's Q1 2025 Portfolio in Review
As of Q1 2025, Dmitry Balyasny held 3,423 positions worth $60.5B, down 9.9% from $67.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Dmitry Balyasny withdrew a net $4.05B in Q1 2025, closing 697 positions and reducing 920 holdings. Its most notable exit was Starbucks, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in AutoZone worth $255M.
- Dmitry Balyasny's largest Q1 2025 buy was AutoZone: 66,934 shares worth $255M.
- Dmitry Balyasny added most to iShares Core S&P 500 ETF in Q1 2025, an estimated $509M increase.
- Dmitry Balyasny's biggest Q1 2025 reduction was Arthur J. Gallagher & Co, cutting an estimated $416M.
- Dmitry Balyasny fully exited Starbucks in Q1 2025, selling an estimated $374M.
- Dmitry Balyasny's ten largest holdings make up 13% of its $60.5B portfolio in Q1 2025.
- Dmitry Balyasny opened 759 new positions and closed 697 in Q1 2025.
- Dmitry Balyasny's portfolio value fell 9.9% quarter-over-quarter to $60.5B.
Based on Balyasny Asset Management's 13F filing for Q1 2025, filed 15 May 2025.